I

Inno-Gene SA
F:WQ3

Watchlist Manager
Inno-Gene SA
F:WQ3
Watchlist
Price: 0.379 EUR Market Closed
Market Cap: €2.4m

Wall St Price Targets

WQ3 Price Targets Summary
Inno-Gene SA

There are no price targets for WQ3.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Inno-Gene SA Competitors:
Price Targets
AGCO
AGCO Corp
28% Upside
SAMG
Silvercrest Asset Management Group Inc
76% Upside

Revenue
Forecast

-15% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-15% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 8 years, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 7 years is 22%.

Gross Profit
Forecast

-20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-20% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Inno-Gene SA

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Inno-Gene SA

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is WQ3's stock price target?
Not Available

WQ3 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Inno-Gene SA?
Projected CAGR
22%

Over the last 8 years, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 7 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett